89bio, Inc. Current Foreign Tax Expense (Benefit)
89bio, Inc. reported Current Foreign Tax Expense (Benefit) of $688.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2025-02-27
- 89bio, Inc. current foreign tax expense (benefit) for fiscal 2024 was $688.00K, a 81.60% decline from fiscal 2023.
- 89bio, Inc. current foreign tax expense (benefit) for fiscal 2023 was $3.74M, a 23275.00% increase from fiscal 2022.
- 89bio, Inc. current foreign tax expense (benefit) for fiscal 2022 was $16.00K, a 1500.00% increase from fiscal 2021.
- 89bio, Inc. current foreign tax expense (benefit) for fiscal 2021 was $1.00K.
| Period end | Current Foreign Tax Expense (Benefit) 11 month | Current Foreign Tax Expense (Benefit) 12 month | Current Foreign Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | $688.00K 10-K · filed 2025-02-27 | ||
| 2023-12-31 | $3.74M 10-K · filed 2025-02-27 | ||
| 2022-12-31 | $16.00K 10-K · filed 2025-02-27 | -$16.00K 10-K · filed 2023-03-15 | |
| 2021-12-31 | $1.00K 10-K · filed 2024-03-01 | -$1.00K 10-K · filed 2022-03-24 | |
| 2019-12-31 | -$30.00K 10-K · filed 2021-03-25 | $30.00K 10-K · filed 2020-03-18 | |
| 2018-12-31 | $48.00K 10-K · filed 2020-03-18 |